-
DE
Zonulin therapy aims to reduce elevated zonulin levels and strengthen the intestinal barrier. It is used in cases of leaky gut syndrome and related health conditions.
Zonulin therapy aims to reduce elevated zonulin levels and strengthen the intestinal barrier. It is used in cases of leaky gut syndrome and related health conditions.
Zonulin therapy is a therapeutic approach focused on regulating the protein zonulin, which controls the permeability of the intestinal lining by opening and closing tight junctions – the microscopic seals between intestinal epithelial cells. When zonulin is chronically overproduced, the intestinal barrier becomes more permeable, a condition commonly referred to as leaky gut syndrome (increased intestinal permeability). Zonulin therapy aims to normalize this condition through targeted interventions.
Zonulin was first described by gastroenterologist Alessio Fasano. It is primarily produced in the small intestinal mucosa and the liver, where it regulates paracellular permeability. Known triggers of elevated zonulin release include:
Elevated zonulin levels have been associated with conditions such as celiac disease, Crohn's disease, irritable bowel syndrome, type 1 diabetes, and various autoimmune disorders.
The primary goal of zonulin therapy is the restoration of an intact intestinal barrier. Specifically, it aims to:
Dietary modification is a central component of zonulin therapy. A low-gluten or gluten-free diet is frequently recommended, as gluten is a well-established stimulator of zonulin release. An anti-inflammatory diet rich in vegetables, dietary fiber, and fermented foods is also commonly advised.
Probiotics (live beneficial microorganisms) and prebiotics (dietary compounds that promote beneficial gut bacteria) can help stabilize the gut microbiome and regulate zonulin production. Certain strains of Lactobacillus and Bifidobacterium have been associated with reductions in intestinal permeability in clinical studies.
Various nutrients and plant-based compounds are used as part of zonulin therapy, including:
Since chronic stress can promote zonulin secretion, stress-reduction strategies – such as meditation, yoga, and breathing exercises – are an important part of a holistic therapeutic approach.
In research settings, the zonulin antagonist larazotide acetate (AT-1001) is being studied for its ability to inhibit the effect of zonulin on tight junctions. This compound is currently in clinical trials, particularly in the context of celiac disease and type 1 diabetes, and has not yet received broad regulatory approval.
Zonulin levels can be measured via a stool test or a blood test. Elevated values may indicate increased intestinal permeability. However, it is important to note that the diagnostic value of these tests remains a topic of debate within the medical community, and elevated levels alone do not constitute a definitive diagnosis. Results should always be interpreted within the broader clinical context.
Research into zonulin therapy is still in an early phase. While the role of zonulin in celiac disease is well established, its relationship to other conditions and the efficacy of specific therapeutic measures are still subjects of ongoing investigation. Patients should seek guidance from qualified healthcare professionals and should not undertake therapy independently without medical supervision.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.